We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$1.6B
AUM Growth
+$129M
Cap. Flow
+$58.7M
Cap. Flow %
3.67%
Top 10 Hldgs %
25.88%
Holding
122
New
4
Increased
17
Reduced
39
Closed
1

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$29.8M
2
GS icon
Goldman Sachs
GS
+$19.9M
3
WFC icon
Wells Fargo
WFC
+$16.5M
4
ABBV icon
AbbVie
ABBV
+$15.2M
5
TFC icon
Truist Financial
TFC
+$14.5M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$23.7M
2
QCOM icon
Qualcomm
QCOM
+$20.1M
3
CVS icon
CVS Health
CVS
+$17.6M
4
VLO icon
Valero Energy
VLO
+$17M
5
ET icon
Energy Transfer Partners
ET
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 16.14%
2 Financials 14.05%
3 Real Estate 11.18%
4 Energy 10.09%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DAL icon
26
Delta Air Lines
DAL
$55.9B
$31.3M 1.96%
535,139
-400
-0.1% -$22.4K
HR icon
27
Healthcare Realty
HR
$7.42B
$28.6M 1.79%
943,500
+137,900
+17% +$4.12M
PAYX icon
28
Paychex
PAYX
$40.4B
$27.7M 1.73%
325,481
-1,300
-0.4% -$110K
MMP
29
DELISTED
Magellan Midstream Partners, L.P.
MMP
$27M 1.69%
428,903
-900
-0.2% -$56.1K
T icon
30
AT&T
T
$165B
$26.9M 1.68%
912,388
-9,003
-1% -$260K
DLR icon
31
Digital Realty Trust
DLR
$73.7B
$26.4M 1.65%
220,324
-500
-0.2% -$61.5K
ARE icon
32
Alexandria Real Estate Equities
ARE
$8.88B
$25.6M 1.6%
158,657
-800
-0.5% -$126K
CVS icon
33
CVS Health
CVS
$137B
$25.6M 1.6%
344,729
-250,200
-42% -$17.6M
DTE icon
34
DTE Energy
DTE
$31.1B
$23.9M 1.49%
215,857
-822
-0.4% -$88.7K
CCI icon
35
Crown Castle
CCI
$32.7B
$23.6M 1.48%
166,235
+37,300
+29% +$5.09M
WM icon
36
Waste Management
WM
$95.9B
$22.8M 1.43%
200,000
C icon
37
Citigroup
C
$222B
$21.1M 1.32%
264,485
-500
-0.2% -$36.9K
INTC icon
38
Intel
INTC
$466B
$20.3M 1.27%
339,282
-2,100
-0.6% -$118K
HD icon
39
Home Depot
HD
$332B
$19.5M 1.22%
89,493
-300
-0.3% -$67.9K
MS icon
40
Morgan Stanley
MS
$337B
$19.2M 1.2%
376,469
-300,300
-44% -$14.2M
IVW icon
41
iShares S&P 500 Growth ETF
IVW
$72.5B
$19M 1.19%
391,636
+600
+0.2% +$27.8K
PLD icon
42
Prologis
PLD
$138B
$18.8M 1.18%
211,400
ABBV icon
43
AbbVie
ABBV
$458B
$17.1M 1.07%
192,800
+182,600
+1,790% +$15.2M
WFC icon
44
Wells Fargo
WFC
$261B
$17M 1.07%
316,700
+314,900
+17,494% +$16.5M
SPG icon
45
Simon Property Group
SPG
$74.5B
$16.3M 1.02%
109,600
+23,600
+27% +$3.54M
WMB icon
46
Williams Companies
WMB
$90.5B
$16M 1%
673,500
+600,100
+818% +$13.7M
MXIM
47
DELISTED
Maxim Integrated Products
MXIM
$16M 1%
259,700
JNJ icon
48
Johnson & Johnson
JNJ
$635B
$15.9M 1%
109,300
OKE icon
49
Oneok
OKE
$58.7B
$15.8M 0.99%
209,300
QCOM icon
50
Qualcomm
QCOM
$176B
$15.7M 0.98%
178,100
-239,800
-57% -$20.1M

Similar funds

Payden & Rygel's Q4 2019 Portfolio in Review

As of Q4 2019, Payden & Rygel held 122 positions worth $1.6B, up 8.8% from $1.47B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Payden & Rygel deployed $58.7M of net new capital in Q4 2019, opening 4 new positions and adding to 17 existing holdings. Its largest new stake was Conagra Brands: 1,027,000 shares worth $35.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was Philip Morris, an estimated $23.7M trimmed.

  • Payden & Rygel's largest Q4 2019 buy was Conagra Brands: 1,027,000 shares worth $35.2M.
  • Payden & Rygel added most to Goldman Sachs in Q4 2019, an estimated $19.9M increase.
  • Payden & Rygel's biggest Q4 2019 reduction was Philip Morris, cutting an estimated $23.7M.
  • Payden & Rygel fully exited ExxonMobil in Q4 2019, selling an estimated $60K.
  • Payden & Rygel's ten largest holdings make up 26% of its $1.6B portfolio in Q4 2019.
  • Payden & Rygel opened 4 new positions and closed 1 in Q4 2019.
  • Payden & Rygel's portfolio value rose 8.8% quarter-over-quarter to $1.6B.

Based on Payden & Rygel's 13F filing for Q4 2019, filed 31 Jan 2020.